Information Journal Paper
APA:
Copy. (2017). First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial. LANCET, 389(10083), 2031-2040. SID. https://sid.ir/paper/747806/en
Vancouver:
Copy. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial. LANCET[Internet]. 2017;389(10083):2031-2040. Available from: https://sid.ir/paper/747806/en
IEEE:
Copy, “First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial,” LANCET, vol. 389, no. 10083, pp. 2031–2040, 2017, [Online]. Available: https://sid.ir/paper/747806/en